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Abstract
The molecular differences between arteries and veins are genetically predetermined and are evident
even before the first embryonic heart beat. Although ephrinB2 and EphB4 are expressed in cells that
will ultimately differentiate into arteries and veins respectively, many other genes have been shown
to play a significant role in cell fate determination. The expression patterns of ephrinB2 and EphB4
are restricted to arterial-venous boundaries, and Eph/ephrin signaling provides repulsive cues at
arterial-venous boundaries that are thought to prevent intermixing of arterial- and venous-fated cells.
However, the maintenance of arterial-venous fate is susceptible to some degree of plasticity. Thus,
in response to signals from the ambient microenvironment and shear stress, there is flow-mediated
intercalation of the arteries and veins that ultimately leads to the formation of a functional, closed-
loop circulation. In addition, cells in the blood vessels of each organ undergo epigenetic, morphologic
and functional adaptive changes that are specific to the proximate function of their cognate organ(s).
These adaptive changes result in an inter-organ and intra-organ vessel heterogeneity that manifest
clinically in a disparate response of different organs to identical risk factors and injury in the same
animal. In this review, we will focus on the molecular and physiologic factors influencing arterial-
venous heterogeneity between and within different organ(s). We will explore arterial-venous
differences in selected organs as well as their respective endothelial cell architectural organization
that results in their inter- and intra-organ heterogeneity.
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Introduction
In vertebrates, blood vessels play a significant role in establishing a circulation that is essential
for gas exchange, delivery of nutrients, removal of metabolic waste, leukocyte trafficking and
providing a means for inter-organ communication 1. The circulatory vasculature is divided into
two distinct and separate networks comprised of arteries and veins. The inner layers of these
blood vessels are ubiquitously lined by endothelial cells whose functions have evolved beyond
nutrient delivery and oxygen transport. In response to cues from the microenvironment,
endothelial cells from these vessels undergo epigenetic, morphologic and functional adaptive
changes that are specific for enhancing the proximate function of their cognate organ(s). These
tissue-specific adaptive changes in vessel architecture provide a fitness advantage that allows
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the endothelium to conform to the diverse needs of the various ambient microenvironments
within and between different tissues/organs. The end result of these adaptive changes is an
inter-organ and intra-organ vessel heterogeneity that manifests pathophysiologically in a
disparate response of blood vessels from different organs to identical risk factors and injury in
the same animal. In this review, we will focus on the molecular and physiologic factors
influencing arterial-venous heterogeneity between and within different organ(s).
Molecular differences among blood vessels
In the vertebrate embryo, arteries and veins have evolved as anatomically distinct but closely
interconnected blood vessels. The formation of the molecular identity of arteries and veins is
a complex process that is genetically predetermined by signaling from several genes. However,
arterial-venous differentiation is susceptible to a significant degree of plasticity. Hemodynamic
changes and ambient physiologic requirements of the microenvironment mediate
differentiation of arterial and venous cells at the arterial-venous boundaries as well as
intercalation of arteries and veins to allow blood to flow from arteries to veins in a closed loop
circulation. Numerous genes play an important role in the complex signaling cascade that result
in arterial-venous differentiation; some of these genes are depicted in Figure 1.
Ephrin/eph-receptor family
Of all the receptor tyrosine kinases that are found in the human genome, the Eph-receptor
family, which has 13 members, constitutes the largest family. Their ligands, the ephrins, are
divided into two subclasses, the A-subclass (ephrinA1-ephrinA5), whose members are tethered
to the cell membrane by a glucosylphosphatidylinositol, and the B-subclass (ephrinB1-
ephrinB3) ligands, which have a transmembrane domain that is followed by a short cytoplasmic
region. Similarly, the Eph receptors are divided into an A-subclass (EphA1-EphA8) and a B-
subclass (EphB1-EphB4, and EphB6). Originally, it was assumed that ephrin subclasses A and
B strictly interacted with their respective Eph receptors; however, the binding preference of
ephrins is now known to be promiscuous as they are not class-restricted 2-4. Since Eph receptors
and ephrin ligands are both membrane bound, binding and activation of Eph and ephrins require
cell-cell interactions. Unlike the ligands of other receptor tyrosine kinases, which act as
agonists in both their soluble and membrane-bound forms, only membrane-bound ephrins are
active— the soluble ephrins act as dominant negative molecules 5, 6. A unique feature of
ephrins is that they are also capable of “receptor-like” signaling resulting in bi-directional
signal transduction with both forward (ephrinB-EphB) signaling and reverse (EphB-ephrinB)
signaling, where the ephrin cytoplasmic tail is phosphorylated and recruits signaling effectors
7, 8 (Figure 2A). In addition to being markers of arteries and veins, other functions that have
been attributed to Eph and ephrins include cell migration, axonal guidance and tissue-border
formation by repulsion of neighboring cells— a function that is important in defining the
arterial-venous borders [9-11].
Arterial and venous specification in the developing embryo is genetically identified through
the distinctive expression of ephrinB2 in cells that will ultimately become arteries and EphB4
(the ephrinB2 receptor) in cells that will ultimately become veins [12-14]. Surprisingly, the
arterial-venous expression of ephrinB2 and EphB4 precedes the formation of morphologically
distinct arteries and veins (that is before the onset of blood flow) 9, 10. Although the expression
patterns of arterial ephrinB2 and venous EphB4 are distinct, interactions between these two
markers are essential for proper vascular development. Mouse mutants defective for both the
ligand ephrinB2 and the receptor EphB4 die at embryonic day 9.5 (E9.5) as a result of defective
remodeling— the primitive blood vessels are formed but the arrangement of the primary
vascular plexus into a hierarchically organized vascular system that consist of large vessels
and capillaries fails to occur [12, 15, 16] (Figure 2B). Consequently, this defect disrupts the
differentiation of blood vessels into morphologically distinguishable arteries and veins.
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Although ephrins and Ephs can restrain cell movement at arterial-venous boundaries (across
which the migration of endothelial cells are restricted), grafted cells retain some degree of
plasticity permitting them to colonize both arteries and veins 11; however, these cells can
change the expression of markers (ephrinB2) to match arterial-venous properties of their host
vessels 12.
Although ephrins and Eph are markers of arteries and veins, studies in zebrafish and mice have
led to the discovery of other critically important genes that are upstream of ephrins and Ephs.
These include sonic hedgehog, notch and its ligands, VEGF, gridlock (grl), neuropilins (nrp),
Sox7/Sox18 and COUP-TFII (Figure 1). Targeted disruption of one or more of these genes or
their ligand leads to perturbation in arterial-venous differentiation. Thus, the intricate genetic
processes that establish the complex vascular system during development depend on the
combinatorial effects of the intrinsic interaction between ephrins and Ephs and their upstream
genes discussed below.
Hedgehog
The Hedgehog family is composed of three ligands—sonic hedgehog, Indian hedgehog and
desert hedgehog, and all three hedgehog ligands are not only expressed in the embryonic and
adult heart (with sonic hedgehog being the most abundant) but also signal through the same
receptors called patched-1 and patched-2 13. Sonic hedgehog induces arterial differentiation
indicating that it is critical for blood vessel development 14, 15. Activation of sonic hedgehog
signaling in the adult heart promotes coronary neovascularization 13. Zebrafish embryos
lacking sonic hedgehog also lack arterial ephrinB2 expression and fail to undergo arterial
differentiation—they retain a single big blood vessel that expresses venous markers 16, 17.
Sonic hedgehog's regulation of arterial fate determination is critically dependent on, and linked
to VEGF expression in the somite 18. VEGF signaling is downstream of sonic hedgehog and
upstream of the notch pathway (Figure 1) in determining arterial cell fate. Loss of VEGF or
sonic hedgehog results in loss of arterial identity, and embryos lacking sonic hedgehog activity
fail to express VEGF within their somites 19. Furthermore, exogenous expression of VEGF
and sonic hedgehog causes ectopic expression of arterial markers, and microinjection of VEGF
mRNA into embryos lacking sonic hedgehog activity rescues arterial differentiation 19; thus,
sonic hedgehog and VEGF play a coordinated role in a complex signaling cascade that
establishes arterial fate.
VEGF-A
In mice, VEGF-A is alternatively spliced into a soluble VEGF120 (which lacks exons 6 and 7)
20, 21, VEGF164 (which lacks exon 6) and VEGF188 (which contains all exons, is insoluble and
binds strongly to cell surface and extracellular matrix). Genetic studies have demonstrated that
specific VEGF isoforms mediate a complex interplay of signaling events that regulates arterial
and venous differentiation. Mice heterozygote for all 3 isoforms and mice that are homozygous
for the VEGF164 isoform develop normal retinal vasculature indicating that these genetic make-
ups confer normal cues for vessel pattern. On the other hand, VEGF120/120 mice have reduced
viability and histologic analysis shows that these mice have evidence of severely impaired
retinal arterial development. Furthermore, VEGF188/188 mice have reduced viability and
normal retinal venous development but a dysfunctional arterial differentiation 21. These
vascular remodeling defects exhibited by VEGF120/120 and VEGF188/188 mice are likely due
to a combinatorial dysfunction in guidance cues from matrix-associated VEGF188 and
diffusible VEGF120 as a result of a genetically induced change in the normal concentration
gradients of VEGF proteins.
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Notch proteins are comprised of four members in mammals (Notch1-Notch4), and bind to one
of five different ligands—Jagged 1-2 or Delta-like (Dll) 1-3 18 and are involved in cell fate
decisions and patterning during embryonic development 22, 23. VEGF-A up-regulates Notch-1
and one of its ligands, Dll-4, in endothelial cells [23, 25, 28-31]. This upregulation of Notch-1
occurs in mice through the activity of transcription factors Foxc1 and Foxc2 24. Notch signaling
leads to the expression of the bHLH transcription factors grl in zebrafish and hesr1/hesr2 in
mice 25, 26. The signaling mechanism of these genes is highly integrated during vessel
development for appropriate vessel identity. For example, deletion of one or both copies of the
Notch effector genes Hey1 or Hey2 results in a defect in ephrinB2 expression and arterial
development while venous specification is generally unaffected 27. Furthermore, both copies
of the Dll-4 gene are important for arterial fate determination since mice with only one copy
suffer from lethality due to abnormalities in the development of the arteries [31, 36, 37]. In
addition, arteriovenous malformations develop when Notch signaling is either reduced [25,
33, 37] or constitutively active 28. Mice defective in the Notch ligand Jagged-1 die from
hemorrhage early during embryogenesis, exhibiting defects in remodeling of the embryonic
and yolk sac vasculature 29.
Several studies have shown that Notch signaling plays a central role in regulating sprouting
angiogenesis 30. When Notch is activated, membrane associated γ-secretase (GSI) cleaves
Notch intracellular domain which becomes translocated to the nucleus where it stimulates
transcription of target genes. Inhibition of Notch signaling either by administration of DAPT
(a GSI inhibitor), endothelial cell-specific deletion of Notch 1, inactivation of one allele of
Notch ligand (Dll-4) 31 or by knockdown of Rbpsuch (a DNA-binding protein that mediates
transcription of Notch target genes) 32 enhance sprouting angiogenesis and vascular density.
Conversely, angiogenic sprouting is inhibited either by activation of Notch signaling by jagged
1 peptide 31 (a Notch ligand), or by simultaneous inhibition of Dll-4 and VEGF-A signaling
33. Taken together, these data indicate that endothelial cells are dependent on VEGF-A from
the microenvironment to turn on angiogenic sprouting and on Dll-4/Notch signaling to be
resistant to VEGF-A signaling and turn off sprouting angiogenesis. It is tempting to speculate
that the differential effects of Notch-induced alteration in angiogenic sprouting can lead to
variegation in vessel patterning that may be a catalyst for arterial-venous heterogeneity.
Gridlock
Notch activation leads to the expression of the bHLH transcription factors grl in zebrafish and
hesr1/hesr2 in mice [33, 34, 39]. Grl is downstream of the Notch pathway and is involved in
cell fate decisions made by Notch pathways 34, 35. Zebrafish embryo with homozygote deletion
of grl have characteristic localized vascular defects in the paired lateral dorsal aorta of the
anterior trunk at 24 hours post fertilization, resulting in absence of blood flow in the tail while
retaining normal functioning heart and normal cranial circulation. These localized vascular
defects subsequently lead to development of arterial-venous shunts and development of
collateral blood flow in an attempt to restore blood flow to the abnormally developed distal
aorta. Histologic analysis shows that both caudal artery and caudal veins are present but
collapsed due to absence of circulation; furthermore, these caudal vessels can be recruited
(when collateral vessels have matured) suggesting that grl causes a localized vascular defect
and not a generalized deficiency of caudal vessels 36. These data indicate that grl plays a critical
role in arterial fate determination in the developing embryo.
Neuropilins
Neuropilins, which are cell surface receptors for soluble semaphorins, are part of a large gene
family that controls axon guidance in the nervous system 37, 38. The expression of nrp-1 (an
isoform-specific receptor for human VEGF165 39 or mouse VEGF164 40) and nrp-2 becomes
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restricted to arteries and veins respectively as soon as arteries and veins become
morphologically distinguishable [18, 45]. This restrictive expression pattern of nrp-1 and -2 is
critical to the identity of arteries and veins and is temporally related to the reported expression
of ephrinB2 and EphB4 respectively [12, 15, 16]. Targeted deletion of the nrp-1 gene in mouse
results in embryonic lethality at different time points depending on the genetic background —
E10.5 on a C57BL/6 background and E13.5 on a CD1 background 41-43. On a CD1 background,
nrp-1-null mouse embryos have an abnormal vascular network formation in the yolk sac,
defects in aortic arches, abnormality of the outflow tract 42 and defective sprouting of hindbrain
vessels 44. On a C57BL/6 background, nrp-1-null mouse embryos show severe vascular defects
that are due to nrp-1 deletion but which only become apparent after the onset of blood flow
43. Histologic analysis shows formation of the dorsal aorta at the normal time point (E8.5) that
subsequently regresses at E9.5 due to abnormal remodeling, partly due to the lack of
recruitment of smooth muscle cells to larger vessels. Furthermore, nrp-1-null mice on a C57BL/
6 background undergo normal yolk sac vasculogenesis but fail to undergo vascular remodeling
that normally begins after the onset of blood flow, resulting in vascular defects consisting of
poorly branched and enlarged yolk sac vessel with large avascular spaces.
Sox
Recently, Sox7 and Sox18 have been shown to play a significant role in arterial fate
determination 45. Members of the Sox-F family play crucial roles during the formation of
definitive endoderm 46, hematopoietic stem cell regulation, cell fate determination 47 and
cardiovascular development 47. Simultaneous knockdown of Sox7 and Sox18 induces a loss of
posterior circulation and development of arterial-venous shunt; however, loss of either gene
independently does not result in any observed vascular defect 45, 48. In addition, embryos with
Sox7/Sox18 double knockdown have a dramatic decrease in arterial markers like Notch3,
ephrinB2a and Dll-4 and increased expression of venous markers like dab2 and flt4 in arterial
tissues 45. These observations suggest that although Sox7 and Sox18 are individually
dispensable during vascular development, they play a synergistic role in arterial specification
and remodeling and that they are upstream of Notch and Dll-4.
COUP-TFII
The discovery of the arterial specification pathways raises the question of whether venous
development is the default state. This possibility was refuted with the identification of COUP-
TFII, a member of the orphan nuclear receptor superfamily that plays a critical role in active
vein specification 49. Studies of the role of COUP-TFII using COUP-TFII/lacZ “knock-in”
mouse models have shown that COUP-TFII expression occurs in the venous endothelium at
embryonic E8.5. High levels of COUP-TFII are detected in the anterior cardinal vein, umbilical
vein and vitelline vein, but not arterial endothelial cells including dorsal aorta, internal carotid
artery and umbilical artery 49. Genetic ablation of COUP-TFII in endothelial cells enables veins
to acquire arterial characteristics, including the expression of arterial markers (nrp-1) and
Notch signaling molecules. Ectopic expression of COUP-TFII in endothelial cells results in
inhibition of nrp-1 expression and effectively the downstream Notch pathway 49 (Figure 1).
These data indicate that COUP-TFII plays a critical role in active vein specification and in
repressing Notch signaling to maintain vein identity.
The dichotomous specification of molecular markers of arteries and veins prior to the first heart
beat does not explain how the attractive and repulsive forces within the boundaries of arteries
and veins allow intercalation of these genetically distinct vessels to form a closed-loop
circulation. Fluorescence data have shown that individual angioblasts give rise to either arterial
or venous (but not mixed) clones 25, which is consistent with the genetic predisposition
theorem. However, data from the avian model showing that endothelial cells can still become
incorporated into the venous system after acquiring the expression of arterial-specific genes
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(ephrinB2 and nrp-1) suggest that vascular identity, although genetically predetermined, is
reversible during the embryonic period 12, 50. Modern techniques using time-lapse video
microscopic analysis have shown small caliber arteries can disconnect from the growing artery
only to be subsequently reconnected to the veins 51 — thus providing a mechanism for the
formation of a closed loop circulation. Taken together, these data suggest that, prior to the onset
of the first heartbeat, endothelial cells expressing arterial- and venous-specific markers are
genetically predetermined. However, with onset of blood flow, vessels demonstrate a
significant amount of plasticity with hemodynamic changes within the microenvironment
allowing vessels originally part of the arterial tree to contribute to the venous tree. Due to the
fact that the complex interplay between genetic, hemodynamic and environmental factors in
determining the molecular heterogeneity between arteries and veins is not well understood, the
above review of genetic influences governing vessel identity represents only what is currently
known, and almost certainly represents a gross simplification of this complex process.
Physiological heterogeneity among vessel types
The physiologic differences defining arteries and veins are, in part, predicated on differences
in the type and structural assembly of their underlying endothelial cells, types of gap and tight
junctions as well as presence or absence of basement membrane and fenestrations. In general,
arteries carry oxygenated blood (with the exception of pulmonary arteries), have tighter
endothelial junctions, have thicker tunica media and pulsate. In contrast, veins carry
deoxygenated blood (with the exception of pulmonary veins), have looser endothelial
junctions, have thinner tunica media, do not pulsate and have greater capacity to mediate
inflammatory responses 52. In addition to the primary physiological differences demarcating
arteries from veins, each organ influences the architectural organization of its specific vessels
such that it is best suited for the cognate organ-specific function. We will now examine the
physiologic heterogeneity in selected organs and discuss organ-specific plasticity when
appropriate.
Renal vessels
The kidney is a highly vascular organ that has three identified ontogenic stages during
development 53. Blood enters the kidneys through the renal artery that subsequently branches
into afferent arterioles before blood exits the kidney via efferent arterioles. In the mature
functioning kidney, renal vessels have evolved as size- and charge-specific filters in order to
provide organ-specific function 54. These specialized vessels are not only permeable to water
and small solutes but are also relatively permeable to certain macromolecules like renin (∼40
kDa) through specialized filtration barriers. The filtration barrier in the glomerular vessels
consist of glomerular endothelial cells covered with a surface layer of membrane-associated
proteoglycans, glycosaminoglycans, glycoproteins, glycolipids and associated plasma proteins
(known collectively as the glycocalyx 55), the glomerular basement membrane, glomerular
epithelial cells and podocytes 56 (Figure 3A). The glomerular endothelial cells, which form the
initial filtration barrier to blood flow through the kidney, possess continuous fenestrations 57,
58 with specialized slit-pore diaphragms 59. The pores have uneven diameters ranging between
60 and 240 nm that allow bulk fluid and anionically charged molecules to be filtered and
facilitate movement of cationically charged molecules 60, 61.
The individual renal vessels that form the conduit for this passage of blood display considerable
functional heterogeneity amongst themselves depending on which region of the kidney they
serve. For instance, the glomerular capillaries serve primarily to filter fluids and solutes out of
the blood that enters the kidneys before integrating with the efferent arterioles. The efferent
arterioles subsequently terminate in vasa recta that enter the medulla of the kidney as
descending vasa arterioles (descending vasa recta) before exiting the medulla as ascending
veins (ascending vasa recta). These parallel vascular tubes are structurally distinct (Figure 3B).
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For instance, the descending vasa recta are lined by the continuous and non-fenestrated
endothelium while the ascending vasa recta are lined by lined by fenestrated endothelium.
Furthermore, while blood is flowing through the descending vasa recta into the medulla,
osmotically active solutes, like sodium chloride and urea, are first absorbed into the interstitium
of the descending vasa recta and subsequently released through the interstitium into the
ascending vasa recta. Thus, osmotically active solutes are shuttled between the ascending and
descending capillary within the microcirculation of the medulla as a mechanism for effective
prevention of a wash out of medullary hypertonicity and preservation of medullary
countercurrent exchange which is essential for gradient-mediated filtration in kidneys 62, 63.
This functional heterogeneity between the descending vasa recta and ascending vasa recta also
facilitates shunting of oxygen and other nutrients from the descending arteriole to the ascending
vasa recta 64 within the medulla. Physiologic and immunologic measurements have shown that
aquaporin-1 water channels and the facilitated urea carrier are significantly concentrated in the
descending vasa recta 63, 65, 66 where they facilitate efflux of water from the descending vasa
recta to the papillary interstitium 67-69. Taken together, these studies show that there is a
complex vascular relationship as well as heterogenous transport properties within the renal
vasculature.
Some diseases are due to abnormalities in renal vessels. For example, congenital Finnish
nephritic syndrome, an inherited autosomal recessive trait, results from a defect in Nephrin, a
136 kDa protein that assembles to form an isoporous filter in the glomerulus that is essential
for maintenance of the filtration barrier 70. Mice and humans with defective Nephrin develop
severe proteinuria and diffuse foot-process effacement 71, 72.
Cardiac vessels
In vertebrates, the lumen of the ascending aorta is continuous with that of the coronary arteries
that supplies the myocardium with blood during diastole. As the coronary arteries course
through the epicardium, they branch into several smaller arteries that penetrate the myocardium
(myocardial vessels) and ultimately branch into arterioles and the capillary network that
surround cardiomyocytes. The endocardium which forms the inner lining of cardiac chambers,
on the other hand, is perfused by the entire blood volume inside the heart cavity and has been
shown to act as a sensor of circulating blood volume and as a modulator of cardiac performance,
rhythmicity, and growth via autocrine and paracrine signaling 73, 74.
Although the coronary artery ostium is continuous with the ascending aorta, coronary arteries
do not develop as outgrowths of the ascending aorta 75. Rather, they arise separately from the
proepicardium, a primordium that arises from the septum transversum mesenchyme 76, 77. The
precursor cells in the proepicardium subsequently give rise to the epicardium, coronary
endothelium as well as coronary smooth muscle cells 78, 79. Prior to embryonic day 9.5 in
mouse, the heart is divided into two layers consisting of an outer myocardial layer and inner
endocardial layer. At about embryonic day 10.5, a third layer (epicardium) migrates to the
embryonic heart and invades its outer surface to form a uniform layer of epithelium 78, 80, 81.
In response to fibroblast growth factors, bone morphogenic factors and transforming growth
factor signaling from the myocardium, some of the epicardial derived cells (EPDCs) undergo
epithelial-to-mesenchymal transformation (EMT). Subsequently, thymosin-β4 (Tβ-4) — a G-
protein monomer-binding protein 82 — is secreted from the myocardium and stimulates EPDCs
in a paracrine fashion to migrate to the myocardium where they respond to angiogenic (VEGF/
bFGF) or arterogenic (PDGF/TGF-β) factors that provide the stimulus for onward
differentiation into endothelial or smooth muscle cells that form the coronary vessels 82-87.
The essential role of Tβ-4 in the formation of coronary vessels is evidenced by the fact that
cardiac-specific Tβ-4 knockdown by conditional RNA interference resulted in EPDCs that
undergo EMT but fail to migrate into the myocardium, which not only results in impaired
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coronary vasculogenesis and defective collateral growth but also in the development of
ventricular non-compaction 83 — a thin spongiform appearing myocardium. Friends of GATA
(FOG-2) — a protein that physically associate with the N-terminal zinc finger of GATA-4 —
is also important in the formation of the coronary vessels. FOG-2-deficient mouse embryos
have normally developed epicardium but die at midgestation with a complete absence of
coronary vessels but with no phenotypic defects in systemic vessels 88, 89. Further analysis
shows that the epicardial cells of FOG-2-deficient mice fail to undergo epithelial-to-
mesenchymal transformation that is a critical step in the formation of coronary vessels 89.
The endocardium arises from cardiogenic mesoderm that is derived from the rostral portion of
the primitive streak 90. There is a significant amount of heterogeneity between endocardial and
coronary vascular endothelial cells. The endocardium is typically characterized by the presence
of deeper and more tortuous intercellular clefts, trabeculae and furrous microvilli. These
features of the endocardium allow the myocytes adjacent to the endocardium to be exposed to
a significant amount of blood and nutrients because of markedly increased surface area. In
contrast, myocardial capillaries are characterized by a continuous endothelium, and the
capillary endothelium is in intimate contact with cardiomyocytes. They possess shallower
intercellular clefts and fewer tight junctions. It has been estimated that this intramyocardial
capillary network is so vast that myocardial endothelial cells outnumber cardiomyocytes by a
ratio of 3:1 84. This architectural design is well suited for delivery of adequate blood supply
and nutrients to the fastidious cardiomyocytes.
The cardiac venous system is also unique in its systemic connections. The greater coronary
veins generally parallel the epicardial arteries and drain into the coronary sinus, which in turn
communicates with the inferiolateral portion of the right atrium, where its orifice is guarded
by the Thebesian valve. As with the coronary arteries, the coronary venous system derives
from mesenchymal transformation of the proepicardial organ, although maturation of coronary
veins is delayed in comparison with the coronary arteries 91. The signals that differentiate
coronary arterial and venous differentiation have not been clearly defined, but activation of
Notch-dependent pathways appears to be crucial for this distinction 92. Abnormalities of
arteriovenous communication within the coronary circulation, especially when fistulas result
in communication of the right coronary artery directly with the right ventricle or atrium, are
not uncommon and can be clinically hazardous 93.
Coronary vessels are capable of a certain degree of plasticity. For example, data from coronary
artery bypass grafting surgery and peripheral vascular bypass surgery indicates that placement
of veins into the higher pressure and flow of the arterial circulation results in adaptation of the
vein to the arterial environment; this “arterialization” consists of thickening, fibrosis and
intimal proliferation of intimal cells 84, 94. Thus, saphenous veins that are grafted into arteries
adapt arterial properties over time as the grafted veins develop thicker walls and reduced
permeability, reminiscent of the coronary arteries into which they are grafted 95 and
demonstrate loss of EphB4 expression without increased expression of ephrinB2 96.
Furthermore, human saphenous veins perfused ex vivo under arterial flow conditions produce
increased matrix metalloproteinase-2 97, reduced thrombomodulin 98 and increased endothelial
nitric oxide synthase 99, properties that are reminiscent of arteries. In summary, the origin of
the coronary vessels is unique and distinct from that of the systemic arteries and endocardium.
This may, in part, explain why coronary vessels are more prone to atherosclerotic disease —
the leading cause of mortality in the western world — compared to systemic vessels that are
exposed to similar risk factors.
Hepatic vessels
It is believed that the liver diverticulum forms from a thickening in the ventral foregut endoderm
after induction mediated by the cardiac mesoderm at around E8 in the mouse 100-101. The liver
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has a dual blood supply — hepatic arteries, which deliver well-oxygenated blood to the liver
and portal veins, which deliver poorly oxygenated but nutrient-rich blood from the intestine to
the liver (Figure 4A). The hepatic artery branches into hepatic arterioles before draining into
the capillary bed in the liver parenchyma referred to as the hepatic sinusoid. Blood from the
sinusoid empties into the central vein (Figure 4B), hepatic venules, hepatic veins and then into
inferior vena cava where the blood is recycled to the heart. In contrast to the usual arrangement
of veins in the body, blood in the portal vein empties into the portal venules which drain into
the hepatic sinusoid. As described above, blood in the sinusoid drains into the central vein,
hepatic venules, hepatic veins and then into the inferior vena cava where blood is recirculated
via the heart to the systemic circulation 102.
There is a significant amount of heterogeneity across the liver vasculature. Within the portal
venule, the endothelium is spindle shaped, non-fenestrated and has short microvilli, and as the
portal venules transitions into hepatic sinusoid, the endothelial cells becomes smooth, large
and are enriched with actin fibers 103. This suggests that the site of transition of the portal
venule to sinusoid acts as an inlet sphincter that provides an essential regulatory site for hepatic
sinusoidal blood flow. The endothelial cells within the hepatic sinusoids are characterized by
the presence of large number of sieve-like pores that are about 100 nm in diameter. In addition,
the endothelium is discontinuous and has large membrane-bound, non-diaphragmatic fenestrae
referred to as sinusoidal endothelial fenestrae 103, 104. These sinusoidal fenestrae are dynamic
structures that form complex invaginations in the endothelium and regulate not only the
permeability of the hepatic sinusoids but also sinusoidal blood flow by actomyosin-dependent
contraction and dilation of the sinusoidal fenestrae—an adaptation that provides a mechanism
for regulating blood flow within the sinusoid 102. In addition, large-diameter fenestrae are more
numerous in the portal region of the sinusoid where they rapidly transport plasma into the space
of Disse, thus unloading the effects of arterial jet streams 103. Taken together, these data
suggests that there is a significant amount of intra-organ heterogeneity within the liver
vasculature. Perturbation in liver vasculature is a pathophysiologic mechanism in certain
disease processes of the liver. For example, in fibrosis of the liver, the sinusoids undergo
progressive loss of fenestrae and the formation of continuous basement membrane—a process
involving capillarization and venularization of sinusoids that depends in part on changes in the
activity of angiopoietins 1 and 2 105-107.
Pulmonary vessels
The lung has a dual circulation consisting of a low-pressure, high-volume pulmonary vascular
network that is involved in gas exchange and a high-pressure, low-volume bronchial vascular
system that not only delivers oxygen to the bronchial tree but also play an active role in
thermoregulation, humidification of ambient air and facilitation of immune responses in the
airway. Although knowledge of their embryonic origin is incomplete, it is becoming
increasingly appreciated that the distal microvascular pulmonary vascular networks arise from
blood islands where pluripotent lung mesenchymal cells are induced to differentiate into
endothelial cells. In contrast, proximal pulmonary arteries and veins arise from proliferation
and migration of endothelial cells from existing endothelial-lined vessels. Pulmonary
macrovascular (arteries and veins) and microvascular (capillaries) segments arise
independently and are fused together at the pseudoglandular phase of development 108, 109. In
order to accomplish the diverse functions described above, endothelial cells lining bronchial
vessels undergo adaptive changes that result in vessels that are more permeable and more
responsive to inflammation than their pulmonary vascular counterparts 110, 111. Although there
is less leukocyte margination in the bronchial vessels, they exhibit increased permeability in
response to inhaled antigens and constitutively express E-selectin, suggesting that bronchial
vessels are chronically activated 112, 113.
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During embryogenesis, the pulmonary vessels, which normally receive less than 10% of the
cardiac output, undergo a sudden transition from a low flow, high pressure/resistance state to
a high flow, low pressure/resistance states that allows it to be perfused by highly oxygenated
blood from the lung. A remarkable heterogeneity exists throughout the pulmonary vasculature,
in part, due to the unique tissue and blood microenvironment that exist in different lung
compartments. For instance, endothelial cells in the pulmonary arteries are exposed to mixed
venous blood that is low in oxygen whereas capillary endothelial cells are exposed to arterial
blood gases with high oxygen content. In the intact circulation, pulmonary artery endothelial
cells are aligned in the direction of blood flow, and in vitro pulmonary endothelial cells
similarly align in the direction of flow. Vessel bifurcations introduce non-laminar flow
condition as well as complex transmural pressures that represent highly distinctive
environmental condition that can alter the endothelial cell function. Endothelial cells at
bifurcations are not aligned in the direction of flow where flow is turbulent. Furthermore, lung
microvascular endothelium possesses superior barrier properties in vivo when compared with
either pulmonary arterioles or venules leading to an excess of 100-fold greater restriction to
water permeability 114. Thus, pulmonary arterial and microvascular endothelial cells are clearly
phenotypically distinct.
Although the bronchial and pulmonary vessels are very distinct, pathologic diseases can affect
them equally. For instance, hereditary hemorrhagic telangiectasia, which affects both
pulmonary and bronchial vessels and is associated with arteriovenous malformation, is caused
by mutations in endoglin — an ancillary receptor for transforming growth factor-β1 and -β3
115. Abnormalities in bronchial vessels are implicated in diseases such as asthma 116, 117 where
vascular engorgement and neoangiogenesis in airways contribute to airflow obstruction.
Furthermore, abnormality of the pulmonary endothelium leads to other diseases like sepsis-
induced lung injury where there is increased permeability of the pulmonary endothelium 118.
The greater pulmonary venous circulation is unique in that it carries highly oxygenated blood
to the left atrium for systemic delivery into the arterial circulation. The pulmonary veins derive
as endothelial invaginations in the cranial portion of the sinus venosus during development
119 Abnormalities in development of the pulmonary veins can lead to sinus venosus defects
with abnormal draining of the right pulmonary veins, resulting in intraatrial communication.
Clinical consequences of abnormal pulmonary venous development are not limited to anatomic
defects. After evolving from the sinus venosus, the pulmonary veins become invested with a
myocardial sleeve derived from Pitx2-positive cells from the secondary heart field 120. The
pulmonary myocardium depends on the expression of the transcription factor NKX2.5, and
abnormalities in the development of this pulmonary venous sheath when NKX2.5 activity is
reduced may provide an important substrate for the development of atrial fibrillation 121.
Summary
There are molecular and physiologic distinction between arteries and veins, and the molecular
distinction between arteries and veins are predetermined but remain plastic during
development. The complexity and heterogeneity of endothelial cells that form the inner layer
of these vessels is becoming increasingly apparent as we begin to understand that arterial-
venous identity is influenced not just by intrinsic genetic programs but also by local
hemodynamic cues. Although we have made significant progress towards understanding the
specification of arterial-venous identity and the remodeling process that leads to their
heterogeneity, many more studies remain to be done in order to fully understand this complex
signaling process. A few candidate genes and pathways have been identified and discussed in
this review; however, these pathways are probably not sufficient to fully control the complex
arterial-venous fate decision, and a more complex regulatory pathway will likely be discovered
in the future. An added complexity is the fact that many of the function of the identified gene
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products like ephrins, Ephs VEGF and Notch are not solely confined to cell fate decision as
these same genes are known to mediate multiple other developmental processes in vertebrates.
Future studies should be directed at identifying other signaling pathway that are critical to
arterial-venous determination and to fully understand how hemodynamic factors that
contributes significantly to the remodeling of arteries and veins are fully integrated with genetic
factors and mutually regulated.
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Figure 1. Arterial-venous specification in vertebrate embryo
In response to sonic hedgehog secreted by the notochord, VEGF is secreted by adjacent somite
leading to arterialization of the dorsal aorta. VEGF up-regulates Notch pathway including
Notch-1 and its ligand, Delta-like-4 in nearby endothelial cells through activity of the
transcription factors Foxc1 and Foxc2. Subsequently, there is expression of gridlock (in
zebrafish) and hesr1/hesr2 (in mice) which, in addition to the synergistic action of Sox7 and
Sox18 leads to arterial specification presumably via EphrinB2 activation. In the cardinal vein,
COUP-TFII is required for strong expression of EphB4 and venous differentiation.
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Figure 2. Ephrin B2/EphB4 signaling contributes to the fate of blood vessel identity
A. Schematic diagram showing an ephrinB2-expressing cell interacting with an EphB4-
expressing cell. Interactions between the ligand and receptor cause activation and downstream
signaling events in both cells. EphrinB2 signaling in endothelial cells contributes to an arterial
fate for the cell, while EphB4 signaling results in a venous fate. B. Development of a mature
vascular bed requires interaction between ephrinB2-expressing and EphB4-expressing cells.
This interaction ensures the formation of a hierarchically-organized system consisting of both
arteries and veins of various size as well as a well-defined capillary bed. Mice deficient in both
ephrinB2 and EphB4 die in utero as a result of defective remodeling of the vascular bed. These
mice contain primitive blood vessels that fail to develop into a mature vasculature. These mice
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have no distinguishable arteries or veins. Likewise, all vessels are of the same caliber and no
capilliaries are present.
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Figure 3. Heterogeneity within the renal vessels
A. Each glomerulus is surrounded by multiple layers of cells that serve as a specialized filtration
barrier. Glomerular endothelial cells form the initial barrier to blood flowing through the kidney
and are characterized by numerous fenestrations. B. The vessels of the vasa recta illustrate the
complexity and precise specialization of the renal vascular system. The descending vasa recta
are lined by a continuous endothelium that is punctuated by a high density of aquarporin-1
water channels and urea transporters (see insert). The ascending vasa recta are lined by a
fenestrated endothelium (see insert) and have fewer conducting channels.
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Figure 4. The liver has a dual blood supply
A. Schematic illustration of the arrangement of blood flow in the liver. Blood enters the liver
via 2 major vessels: the hepatic artery (carrying oxygenated blood from the aorta) and the portal
vein (carrying nutrient-rich blood from the intestine). Blood leaves the liver via the hepatic
vein that subsequently drains into the inferior vena cava. B. The vascular arrangement within
a liver lobule. Blood enters the lobule through a branch of the hepatic artery and portal vein
and flows through the sinusoid to the central vein, which in turn empties into the hepatic vein
that leaves the liver and drains into the vena cava.
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